Roche Holding AG
RHHBYFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
62,395
Cost of Revenue
16,283
Gross Profit
46,112
Gross Margin
73.9%
Operating Income
13,417
Operating Margin
21.5%
Net Income
8,277
Net Margin
13.3%
EPS (Basic)
$1.30
EPS (Diluted)
$1.29
EBITDA
16,619
EBITDA Margin
26.6%
2023
12/31/2023
Revenue
60,441
Cost of Revenue
15,597
Gross Profit
44,844
Gross Margin
74.2%
Operating Income
15,395
Operating Margin
25.5%
Net Income
11,498
Net Margin
19.0%
EPS (Basic)
$1.80
EPS (Diluted)
$1.79
EBITDA
18,413
EBITDA Margin
30.5%
2022
12/31/2022
Revenue
65,814
Cost of Revenue
18,837
Gross Profit
44,444
Gross Margin
67.5%
Operating Income
17,476
Operating Margin
26.6%
Net Income
12,421
Net Margin
18.9%
EPS (Basic)
$1.94
EPS (Diluted)
$1.92
EBITDA
20,800
EBITDA Margin
31.6%
2021
12/31/2021
Revenue
62,801
Cost of Revenue
19,703
Gross Profit
43,098
Gross Margin
68.6%
Operating Income
17,283
Operating Margin
27.5%
Net Income
13,930
Net Margin
22.2%
EPS (Basic)
$2.05
EPS (Diluted)
$2.03
EBITDA
22,188
EBITDA Margin
35.3%
2020
12/31/2020
Revenue
58,323
Cost of Revenue
16,354
Gross Profit
41,969
Gross Margin
72.0%
Operating Income
18,543
Operating Margin
31.8%
Net Income
14,295
Net Margin
24.5%
EPS (Basic)
$2.09
EPS (Diluted)
$2.07
EBITDA
22,969
EBITDA Margin
39.4%